ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Conditions:   Hematologic Disorder;   Bleeding Disorder;   Connective Tissue Disorder;   Hemophilia;   Thrombosis;   Von Willebrand Diseases;   Thrombophilia;   Rare Bleeding Disorder;   Platelet Disorder Intervention:   Sponsor:   American Thrombosis and Hemostasis Network Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2020 Category: Research Source Type: clinical trials

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
Condition:   Hemophilia A Intervention:   Biological: Moroctocog-alfa (AF-CC) Sponsor:   Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2020 Category: Research Source Type: clinical trials

A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects
Condition:   Hemophilia B Intervention:   Genetic: SHP648 Sponsor:   Baxalta now part of Shire Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2020 Category: Research Source Type: clinical trials

COVID-19 Related Lockdown Effects On Chronic Diseases
Conditions:   Chronic Coronary Syndrome;   Heart Failure;   AMD and Macular Edema;   Chronic Respiratory Failure;   Hemophilia;   Malignant Hemopathy;   Multiple Sclerosis;   Horton's Disease Interventions:   Other: life questionnaires;   Other: questionnaire Sponsor:   Centre Hospitalier Universitaire Dijon Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2020 Category: Research Source Type: clinical trials

Haemophilia and Bone Loss - PHILEOS Study
Condition:   Hemophilia Interventions:   Radiation: Bone densitometry (BMD);   Biological: Blood sampling for patients only Sponsor:   Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia A Adults
Condition:   Hemophilia A Intervention:   Biological: Recombinant AAV2/6 Human Factor VIII Gene Therapy Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2020 Category: Research Source Type: clinical trials